Press Releases

Date	Title	Company
20-Oct-2022	Kancera reports promising preclinical results from studies of its Fractalkine axis blocking drug candidates in B-cell lymphoma	Kancera
20-Oct-2022	Chiesi and Aptar partner to bring to market Disease Management Platform for patients with asthma and COPD	Chiesi
20-Oct-2022	BD to Showcase its Commitment to Drug Delivery and Packaging Innovation at CPhI Worldwide 2022 Conference	BD (Becton, Dickinson and Company)
20-Oct-2022	STORM Therapeutics to present new data on its lead program STC-15 at the 34th EORTC-NCI-AACR Symposium and the 37th SITC Meeting	STORM Therapeutics
20-Oct-2022	ExeVir Bio Forges Ahead with Unique Next Generation COVID-19 Therapy and Appoints Dr. Jeanne Bolger as Chair of the Board of Directors	ExeVir Bio
20-Oct-2022	Enhanc3D Genomics raises £10 million in Series A financing to advance GenLink3DTM proprietary technology platform	Enhanc3D Genomics
20-Oct-2022	Beckman Coulter Life Sciences Proudly Presenting at American Society of Human Genetics Annual Meeting	Beckman Coulter Life Sciences
20-Oct-2022	PacBio and Twist Bioscience Deliver Initial Portfolio of Target Enrichment Panels for HiFi Sequencing	PacBio
20-Oct-2022	AMSilk Relocate Offices to Support Expansion Plans	AMSilk GmbH
20-Oct-2022	BD to Showcase its Commitment to Drug Delivery and Packaging Innovation at CPhI Worldwide 2022 Conference	B3C newswire
20-Oct-2022	Strategies By Top Companies in the Veterinary Diagnostic Market \| Future Growth Outlook	Wired Release
20-Oct-2022	Medical Radiation Detection Market Insights, and Upcoming Business Opportunities 2030	Wired Release
20-Oct-2022	Upcoming Technological Innovations In The Clinical Trial Supplies Market 2023-2030	Wired Release
20-Oct-2022	Recombinant Therapeutic Antibodies and Proteins Market Research Valued US$ 1,76,631.8 Million by 2030 with CAGR of 12.2%	Wired Release
20-Oct-2022	First successful year on the market for Marinomed’s Solv4U technology partnerships	Marinomed Biotech AG
20-Oct-2022	After the first nine months, the Zur Rose Group is at the upper end of targets for revenue and EBITDA for 2022	Zur Rose Group AG
20-Oct-2022	Cosmo announces FDA grants orphan-drug designation of rifamycin for treatment of pouchitis	Cosmo Pharmaceuticals N.V.
19-Oct-2022	AEVIS VICTORIA SA – AEVS.SW – Repayment of the CHF 145 million bond issued on 17 October 2016	AEVIS VICTORIA SA
19-Oct-2022	TrialAssure Surpasses Milestone 30 Million Markups in its Pharmaceutical Document Anonymization Software	TrialAssure
19-Oct-2022	Creative Peptides Rolls Out Ready-to-Ship Fmoc-Tyr(HP03Bzl)-OH Product from Small Quantity to Large Scale	Creative Peptides